-
Cowen and Company 37th AnnualHealth Care Conference onTuesday, March 7 , at8:40 a.m. ET at theBoston Marriott Copley Place ,Boston, Massachusetts -
Barclays Global Healthcare Conference onTuesday, March 14 , at10:15 a.m. ET at theLoews Miami Beach Hotel ,Miami, Florida
To access the live webcast of bluebird bio’s presentations, please visit the “Calendar of Events” page within the Investors and Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcast will be available on the bluebird bio website for 90 days following the conference.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning
of the Private Securities Litigation Reform Act of 1995, including
statements regarding the Company’s product candidates and research
programs. Any forward-looking statements are based on management’s
current expectations of future events and are subject to a number of
risks and uncertainties that could cause actual results to differ
materially and adversely from those set forth in or implied by such
forward-looking statements. These risks and uncertainties include, but
are not limited to, risks that the preliminary results from our clinical
trials will not continue or be repeated in our ongoing clinical trials,
the risk of cessation or delay of any of the ongoing or planned clinical
studies and/or our development of our product candidates, the risk of a
delay in the enrollment of patients in our clinical studies, risks that
the current or planned clinical trials of the LentiGlobin drug product
will be insufficient to support regulatory submissions or marketing
approval in the
View source version on businesswire.com: http://www.businesswire.com/news/home/20170228005685/en/
Source: bluebird bio, Inc.
Investors:
bluebird bio, Inc.
Manisha Pai, 617-245-2107
mpai@bluebirdbio.com
or
Media:
bluebird
bio, Inc.
Elizabeth Pingpank, 617-914-8736
epingpank@bluebirdbio.com
or
Pure
Communications, Inc.
Dan Budwick, 973-271-6085